Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.

Faulkner MA.

CNS Drugs. 2018 Feb;32(2):149-159. doi: 10.1007/s40263-018-0502-z. Review.

PMID:
29480463
2.

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.

Garcia-Borreguero D, Kohnen R, Silber MH, Winkelman JW, Earley CJ, Högl B, Manconi M, Montplaisir J, Inoue Y, Allen RP.

Sleep Med. 2013 Jul;14(7):675-84. doi: 10.1016/j.sleep.2013.05.016.

3.

Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.

Garcia-Borreguero D, Silber MH, Winkelman JW, Högl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP.

Sleep Med. 2016 May;21:1-11. doi: 10.1016/j.sleep.2016.01.017. Epub 2016 Feb 23.

4.

Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.

Iftikhar IH, Alghothani L, Trotti LM.

Eur J Neurol. 2017 Dec;24(12):1446-1456. doi: 10.1111/ene.13449. Epub 2017 Oct 5. Review.

PMID:
28888061
5.

Restless legs syndrome: pathophysiology and modern management.

Nagandla K, De S.

Postgrad Med J. 2013 Jul;89(1053):402-10. doi: 10.1136/postgradmedj-2012-131634. Epub 2013 Mar 22. Review.

PMID:
23524988
6.

Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome.

Imamura S, Kushida C.

Expert Opin Pharmacother. 2010 Aug;11(11):1925-32. doi: 10.1517/14656566.2010.494598. Review.

PMID:
20629607
7.

New treatment options for the management of restless leg syndrome.

Toro BE.

J Neurosci Nurs. 2014 Aug;46(4):227-32. doi: 10.1097/JNN.0000000000000068. Review.

PMID:
24992148
8.

Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).

Burke RA, Faulkner MA.

Expert Opin Pharmacother. 2011 Dec;12(18):2905-14. doi: 10.1517/14656566.2011.635645. Epub 2011 Nov 14. Review.

PMID:
22077768
9.

Pregabalin for the Treatment of Restless Legs Syndrome.

Griffin E, Brown JN.

Ann Pharmacother. 2016 Jul;50(7):586-91. doi: 10.1177/1060028016643097. Epub 2016 Apr 18. Review.

PMID:
27091870
10.

What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.

Hornyak M, Scholz H, Kohnen R, Bengel J, Kassubek J, Trenkwalder C.

Sleep Med Rev. 2014 Apr;18(2):153-64. doi: 10.1016/j.smrv.2013.03.004. Epub 2013 Jun 6. Erratum in: Sleep Med Rev. 2014 Aug;18(4):367-8.

PMID:
23746768
11.

Gabapentin enacarbil in restless legs syndrome.

Merlino G, Serafini A, Lorenzut S, Sommaro M, Gigli GL, Valente M.

Drugs Today (Barc). 2010 Jan;46(1):3-11. doi: 10.1358/dot.2010.46.1.1424766. Review.

PMID:
20200691
12.

Therapeutic dilemma for restless legs syndrome.

Chokroverty S.

N Engl J Med. 2014 Feb 13;370(7):667-8. doi: 10.1056/NEJMe1313155. No abstract available.

PMID:
24521115
13.

Latest guidelines and advances for treatment of restless legs syndrome.

Earley CJ.

J Clin Psychiatry. 2014 Apr;75(4):e08. doi: 10.4088/JCP.12074nr3c. Review.

14.

ADMET considerations for restless leg syndrome drug treatments.

de Biase S, Merlino G, Lorenzut S, Valente M, Gigli GL.

Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1247-61. doi: 10.1517/17425255.2012.708023. Epub 2012 Jul 18. Review.

PMID:
22808933
15.

Restless legs syndrome-current therapies and management of augmentation.

Trenkwalder C, Winkelmann J, Inoue Y, Paulus W.

Nat Rev Neurol. 2015 Aug;11(8):434-45. doi: 10.1038/nrneurol.2015.122. Epub 2015 Jul 28. Review.

PMID:
26215616
16.

Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).

Garcia-Borreguero D, Cano-Pumarega I, Marulanda R.

Sleep Med Rev. 2018 Oct;41:50-60. doi: 10.1016/j.smrv.2018.01.001. Epub 2018 Jan 9. Review.

PMID:
29602660
17.

A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.

Allen R, Chen C, Soaita A, Wohlberg C, Knapp L, Peterson BT, García-Borreguero D, Miceli J.

Sleep Med. 2010 Jun;11(6):512-9. doi: 10.1016/j.sleep.2010.03.003. Epub 2010 May 13.

PMID:
20466589
18.

Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.

Merlino G, Serafini A, Young JJ, Robiony F, Gigli GL, Valente M.

Curr Opin Investig Drugs. 2009 Jan;10(1):91-102.

PMID:
19127491
19.

Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.

Inoue Y, Uchimura N, Kuroda K, Hirata K, Hattori N.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):251-7. doi: 10.1016/j.pnpbp.2011.10.009. Epub 2011 Oct 19.

PMID:
22036917
20.

Treatment of restless legs syndrome.

Comella CL.

Neurotherapeutics. 2014 Jan;11(1):177-87. doi: 10.1007/s13311-013-0247-9. Review.

Supplemental Content

Support Center